PL3551189T3 - Alprazolam do stosowania w leczeniu padaczki - Google Patents

Alprazolam do stosowania w leczeniu padaczki

Info

Publication number: PL3551189T3
Authority: PL; Poland
Prior art keywords: alprazolam; treating epilepsy; epilepsy; treating
Prior art date: 2016-12-09

Application number

PL17878604.2T

Other languages

English (en)

Inventor

James Cassella

Lily GONG

Edwin S. KAMEMOTO

Original Assignee

Alexza Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-12-09

Filing date

2017-12-08

Publication date

2024-04-22

2017-12-08 Application filed by Alexza Pharmaceuticals, Inc. filed Critical Alexza Pharmaceuticals, Inc.

2024-04-22 Publication of PL3551189T3 publication Critical patent/PL3551189T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Dispersion Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL17878604.2T 2016-12-09 2017-12-08 Alprazolam do stosowania w leczeniu padaczki PL3551189T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201662432353P	2016-12-09	2016-12-09
US201762485281P	2017-04-13	2017-04-13
PCT/US2017/065347 WO2018107045A1 (en)	2016-12-09	2017-12-08	Method of treating epilepsy

Publications (1)

Publication Number	Publication Date
PL3551189T3 true PL3551189T3 (pl)	2024-04-22

Family

ID=62492165

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL17878604.2T PL3551189T3 (pl)	2016-12-09	2017-12-08	Alprazolam do stosowania w leczeniu padaczki

Country Status (20)

Country	Link
US (3)	US11241383B2 (pl)
EP (2)	EP3551189B1 (pl)
JP (3)	JP7379154B2 (pl)
KR (3)	KR20220164620A (pl)
CN (2)	CN110267662A (pl)
AU (3)	AU2017370747A1 (pl)
CA (1)	CA3046385C (pl)
DK (1)	DK3551189T3 (pl)
ES (1)	ES2968097T3 (pl)
FI (1)	FI3551189T3 (pl)
HR (1)	HRP20240106T1 (pl)
HU (1)	HUE064864T2 (pl)
IL (1)	IL267199A (pl)
LT (1)	LT3551189T (pl)
MX (2)	MX2019006745A (pl)
PL (1)	PL3551189T3 (pl)
PT (1)	PT3551189T (pl)
RS (1)	RS65112B1 (pl)
SI (1)	SI3551189T1 (pl)
WO (1)	WO2018107045A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080216828A1 (en)	2007-03-09	2008-09-11	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
US20120048963A1 (en)	2010-08-26	2012-03-01	Alexza Pharmaceuticals, Inc.	Heat Units Using a Solid Fuel Capable of Undergoing an Exothermic Metal Oxidation-Reduction Reaction Propagated without an Igniter
MX2017011613A (es)	2015-03-11	2018-04-10	Alexza Pharmaceuticals Inc	Utilización de materiales antiestáticos en los conductos de aire para el proceso de aerosol de condensación térmica.
PL3551189T3 (pl)	2016-12-09	2024-04-22	Alexza Pharmaceuticals, Inc.	Alprazolam do stosowania w leczeniu padaczki
EP3806673A1 (en) *	2018-06-14	2021-04-21	Philip Morris Products S.A.	Aerosol-generating device with planar heater

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3987052A (en)	1969-03-17	1976-10-19	The Upjohn Company	6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
US7845346B2 (en) *	2000-08-18	2010-12-07	Norton Healthcare Ltd.	Spray device
US6613308B2 (en)	2000-09-19	2003-09-02	Advanced Inhalation Research, Inc.	Pulmonary delivery in treating disorders of the central nervous system
US7498019B2 (en)	2001-05-24	2009-03-03	Alexza Pharmaceuticals, Inc.	Delivery of compounds for the treatment of headache through an inhalation route
US20030118512A1 (en)	2001-10-30	2003-06-26	Shen William W.	Volatilization of a drug from an inclusion complex
US20080038363A1 (en)	2001-05-24	2008-02-14	Zaffaroni Alejandro C	Aerosol delivery system and uses thereof
US20030131843A1 (en)	2001-11-21	2003-07-17	Lu Amy T.	Open-celled substrates for drug delivery
US6759029B2 (en)	2001-05-24	2004-07-06	Alexza Molecular Delivery Corporation	Delivery of rizatriptan and zolmitriptan through an inhalation route
US7090830B2 (en)	2001-05-24	2006-08-15	Alexza Pharmaceuticals, Inc.	Drug condensation aerosols and kits
US20070122353A1 (en)	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
US6805853B2 (en)	2001-11-09	2004-10-19	Alexza Molecular Delivery Corporation	Delivery of diazepam through an inhalation route
US6737042B2 (en)	2001-05-24	2004-05-18	Alexza Molecular Delivery Corporation	Delivery of drug esters through an inhalation route
US7585493B2 (en)	2001-05-24	2009-09-08	Alexza Pharmaceuticals, Inc.	Thin-film drug delivery article and method of use
US7458374B2 (en)	2002-05-13	2008-12-02	Alexza Pharmaceuticals, Inc.	Method and apparatus for vaporizing a compound
US20030138508A1 (en)	2001-12-18	2003-07-24	Novack Gary D.	Method for administering an analgesic
EP1392260A2 (en) *	2001-05-24	2004-03-03	Alexza Molecular Delivery Corporation	Delivery of benzodiazepines through an inhalation route
US7645442B2 (en)	2001-05-24	2010-01-12	Alexza Pharmaceuticals, Inc.	Rapid-heating drug delivery article and method of use
EP1392258B1 (en)	2001-05-24	2008-11-26	Alexza Pharmaceuticals, Inc.	Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
US7766013B2 (en)	2001-06-05	2010-08-03	Alexza Pharmaceuticals, Inc.	Aerosol generating method and device
AU2002363947A1 (en)	2001-11-21	2003-07-24	Alexza Molecular Delivery Corporation	Delivery of caffeine through an inhalation route
MXPA04010990A (es)	2002-05-07	2005-02-14	Nektar Therapeutics	Capsulas para inhaladores de polvo seco y metodo s para elaborarlas y utilizarlas.
EP1503744A1 (en)	2002-05-13	2005-02-09	Alexza Molecular Delivery Corporation	Delivery of drug amines through an inhalation route
US20060193788A1 (en)	2002-11-26	2006-08-31	Hale Ron L	Acute treatment of headache with phenothiazine antipsychotics
US20040101481A1 (en)	2002-11-26	2004-05-27	Alexza Molecular Delivery Corporation	Acute treatment of headache with phenothiazine antipsychotics
ATE420647T1 (de)	2002-11-26	2009-01-15	Alexza Pharmaceuticals Inc	Verwendung von loxapine für die herstellung eines mittels zur behandlung von schmerz
US7550133B2 (en)	2002-11-26	2009-06-23	Alexza Pharmaceuticals, Inc.	Respiratory drug condensation aerosols and methods of making and using them
US20040105818A1 (en)	2002-11-26	2004-06-03	Alexza Molecular Delivery Corporation	Diuretic aerosols and methods of making and using them
US7913688B2 (en)	2002-11-27	2011-03-29	Alexza Pharmaceuticals, Inc.	Inhalation device for producing a drug aerosol
EP1625333A1 (en)	2003-05-21	2006-02-15	Alexza Pharmaceuticals, Inc.	Self-contained heating unit and drug-supply unit employing same
WO2005016421A1 (en)	2003-08-04	2005-02-24	Alexza Pharmaceuticals, Inc.	Substrates for drug delivery device and methods of preparing and use
US20050037506A1 (en)	2003-08-04	2005-02-17	Alexza Molecular Delivery Corporation	Methods of determining film thicknesses for an aerosol delivery article
AU2004305518A1 (en)	2003-12-15	2005-07-07	Alexza Pharmaceuticals, Inc.	Treatment of breakthrough pain by drug aerosol inhalation
WO2005059804A2 (en)	2003-12-16	2005-06-30	Alexza Pharmaceuticals, Inc.	Methods for monitoring severity of panic attacks and other rapidly evolving medical events in real-time
US7402777B2 (en)	2004-05-20	2008-07-22	Alexza Pharmaceuticals, Inc.	Stable initiator compositions and igniters
US7540286B2 (en)	2004-06-03	2009-06-02	Alexza Pharmaceuticals, Inc.	Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US20100006092A1 (en)	2004-08-12	2010-01-14	Alexza Pharmaceuticals, Inc.	Aerosol Drug Delivery Device Incorporating Percussively Activated Heat Packages
CA2576961A1 (en)	2004-08-12	2006-03-02	Alexza Pharmaceuticals, Inc.	Aerosol drug delivery device incorporating percussively activated heat packages
US20060032496A1 (en)	2004-08-12	2006-02-16	Alexza Molecular Delivery Corporation	Inhalation actuated percussive ignition system
US20060120962A1 (en) *	2004-10-12	2006-06-08	Rabinowitz Joshua D	Cardiac safe, rapid medication delivery
CA2597716A1 (en)	2005-02-15	2006-08-24	Elan Pharma International Limited	Aerosol and injectable formulations of nanoparticulate benzodiazepine
EP1959966B1 (en) *	2005-11-28	2020-06-03	Marinus Pharmaceuticals, Inc.	Ganaxolone formulations and methods for the making and use thereof
US7494344B2 (en)	2005-12-29	2009-02-24	Molex Incorporated	Heating element connector assembly with press-fit terminals
US20080299048A1 (en)	2006-12-22	2008-12-04	Alexza Pharmaceuticals, Inc.	Mixed drug aerosol compositions
US7513781B2 (en)	2006-12-27	2009-04-07	Molex Incorporated	Heating element connector assembly with insert molded strips
US20080216828A1 (en)	2007-03-09	2008-09-11	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
WO2008134668A2 (en)	2007-04-27	2008-11-06	Alexza Pharmaceuticals, Inc.	Heat-labile prodrugs
US20080279784A1 (en) *	2007-05-07	2008-11-13	Questcor Pharmaceuticals, Inc.	Nasal administration of benzodiazepines
US20090180968A1 (en)	2008-01-11	2009-07-16	Alexza Pharmaceuticals, Inc.	Metal Coordination Complexes Of Volatile Drugs
CN102088990A (zh) *	2008-05-16	2011-06-08	阿尔伯维塔公司	癫痫的治疗
US20100068155A1 (en)	2008-09-16	2010-03-18	Alexza Pharmaceuticals, Inc.	Reactant Formulations and Methods for Controlled Heating
US7834295B2 (en)	2008-09-16	2010-11-16	Alexza Pharmaceuticals, Inc.	Printable igniters
US20100065052A1 (en)	2008-09-16	2010-03-18	Alexza Pharmaceuticals, Inc.	Heating Units
US20100300433A1 (en)	2009-05-28	2010-12-02	Alexza Pharmaceuticals, Inc.	Substrates for Enhancing Purity or Yield of Compounds Forming a Condensation Aerosol
US20100181387A1 (en) *	2009-12-01	2010-07-22	Zaffaroni Alejandro C	Aerosol delivery system and uses thereof
US20120048963A1 (en)	2010-08-26	2012-03-01	Alexza Pharmaceuticals, Inc.	Heat Units Using a Solid Fuel Capable of Undergoing an Exothermic Metal Oxidation-Reduction Reaction Propagated without an Igniter
WO2012075286A2 (en)	2010-12-01	2012-06-07	The Regents Of The University Of California	Intrapulmonary benzodiazepine for the treatment and prevention of seizures
CA2817654A1 (en) *	2010-12-02	2012-06-07	Ucb Pharma Gmbh	Once daily formulation of lacosamide
EP4085899A1 (en) *	2011-06-14	2022-11-09	Neurelis, Inc.	Administration of benzodiazepine
AU2012358872A1 (en) *	2011-12-20	2014-07-10	Map Pharmaceuticals, Inc.	Excipient-free aerosol formulation
ES2821907T3 (es)	2013-07-11	2021-04-28	Alexza Pharmaceuticals Inc	Sal de nicotina con ácido metasalicílico
MX2017011613A (es)	2015-03-11	2018-04-10	Alexza Pharmaceuticals Inc	Utilización de materiales antiestáticos en los conductos de aire para el proceso de aerosol de condensación térmica.
PL3551189T3 (pl)	2016-12-09	2024-04-22	Alexza Pharmaceuticals, Inc.	Alprazolam do stosowania w leczeniu padaczki

2017
- 2017-12-08 PL PL17878604.2T patent/PL3551189T3/pl unknown
- 2017-12-08 FI FIEP17878604.2T patent/FI3551189T3/fi active
- 2017-12-08 KR KR1020227041634A patent/KR20220164620A/ko active Application Filing
- 2017-12-08 RS RS20240089A patent/RS65112B1/sr unknown
- 2017-12-08 US US16/469,143 patent/US11241383B2/en active Active
- 2017-12-08 LT LTEPPCT/US2017/065347T patent/LT3551189T/lt unknown
- 2017-12-08 HR HRP20240106TT patent/HRP20240106T1/hr unknown
- 2017-12-08 EP EP17878604.2A patent/EP3551189B1/en active Active
- 2017-12-08 MX MX2019006745A patent/MX2019006745A/es unknown
- 2017-12-08 KR KR1020197019402A patent/KR20190104531A/ko not_active IP Right Cessation
- 2017-12-08 EP EP23200086.9A patent/EP4272827A3/en active Pending
- 2017-12-08 JP JP2019531043A patent/JP7379154B2/ja active Active
- 2017-12-08 PT PT178786042T patent/PT3551189T/pt unknown
- 2017-12-08 ES ES17878604T patent/ES2968097T3/es active Active
- 2017-12-08 KR KR1020237015165A patent/KR20230066655A/ko not_active Application Discontinuation
- 2017-12-08 SI SI201731475T patent/SI3551189T1/sl unknown
- 2017-12-08 HU HUE17878604A patent/HUE064864T2/hu unknown
- 2017-12-08 AU AU2017370747A patent/AU2017370747A1/en not_active Abandoned
- 2017-12-08 DK DK17878604.2T patent/DK3551189T3/da active
- 2017-12-08 CN CN201780086216.6A patent/CN110267662A/zh active Pending
- 2017-12-08 CA CA3046385A patent/CA3046385C/en active Active
- 2017-12-08 CN CN202310415295.8A patent/CN116172985A/zh active Pending
- 2017-12-08 WO PCT/US2017/065347 patent/WO2018107045A1/en active Application Filing
2019
- 2019-06-07 MX MX2022008775A patent/MX2022008775A/es unknown
- 2019-06-10 IL IL267199A patent/IL267199A/en unknown
2021
- 2021-04-28 AU AU2021202621A patent/AU2021202621B2/en active Active
- 2021-04-30 US US17/244,963 patent/US11717479B2/en active Active
- 2021-06-02 JP JP2021093227A patent/JP7376532B2/ja active Active
2022
- 2022-04-14 US US17/721,183 patent/US12133915B2/en active Active
- 2022-12-13 AU AU2022287583A patent/AU2022287583A1/en active Pending
2023
- 2023-05-01 JP JP2023075804A patent/JP2023118696A/ja active Pending

Also Published As

Publication number	Publication date
EP3551189A1 (en)	2019-10-16
HUE064864T2 (hu)	2024-04-28
US12133915B2 (en)	2024-11-05
JP2021154135A (ja)	2021-10-07
CA3046385C (en)	2023-12-19
CA3046385A1 (en)	2018-06-14
EP3551189A4 (en)	2020-07-22
AU2017370747A1 (en)	2019-06-27
KR20220164620A (ko)	2022-12-13
AU2021202621B2 (en)	2022-09-15
EP4272827A3 (en)	2024-01-24
US11717479B2 (en)	2023-08-08
PT3551189T (pt)	2024-01-22
KR20230066655A (ko)	2023-05-16
KR20190104531A (ko)	2019-09-10
CN116172985A (zh)	2023-05-30
LT3551189T (lt)	2024-02-12
FI3551189T3 (fi)	2024-01-31
SI3551189T1 (sl)	2024-03-29
ES2968097T3 (es)	2024-05-07
MX2022008775A (es)	2022-07-27
JP7376532B2 (ja)	2023-11-08
MX2019006745A (es)	2019-10-14
EP4272827A2 (en)	2023-11-08
DK3551189T3 (da)	2024-01-29
US20190307680A1 (en)	2019-10-10
AU2022287583A1 (en)	2023-02-02
EP3551189B1 (en)	2023-11-01
US20210244661A1 (en)	2021-08-12
JP2020500911A (ja)	2020-01-16
AU2021202621A1 (en)	2021-05-27
IL267199A (en)	2019-08-29
RS65112B1 (sr)	2024-02-29
WO2018107045A1 (en)	2018-06-14
CN110267662A (zh)	2019-09-20
HRP20240106T1 (hr)	2024-04-12
US11241383B2 (en)	2022-02-08
JP7379154B2 (ja)	2023-11-14
US20220241191A1 (en)	2022-08-04
JP2023118696A (ja)	2023-08-25

Publication	Publication Date	Title
HK1253580A1 (zh)	2019-06-21	大麻二酚在治療癲癇中的用途
IL259795A (en)	2018-07-31	Methods and compositions for treating diseases associated with serpinc1
HK1244686A1 (zh)	2018-08-17	胰腺炎治療
PT3334422T (pt)	2020-09-29	Utilização de ácido canabidiólico no tratamento de epilepsia
IL272596A (en)	2020-03-31	Pridopidine for use in the treatment of ALS
IL259992B (en)	2021-03-25	Compounds for use in methods for treating hyperalgesia
SI3307296T1 (sl)	2022-04-29	TIMP2 za uporabo pri zdravljenju s starostjo povezanih stanj
HK1244217A1 (zh)	2018-08-03	用於治療蛋白質病的方法
HK1251965A1 (zh)	2019-05-10	用於治療癲癇的方法
RS65112B1 (sr)	2024-02-29	Alprazolam za upotrebu u lečenju epilepsije
EP3736275C0 (en)	2024-07-03	PRODRUGS OF OXABICYCLOHEPTANE FOR USE IN THE TREATMENT OF CANCER
SI3406258T1 (sl)	2022-07-29	Zdravilo za zdravljenje putike
SG11201710686PA (en)	2018-01-30	Hair treatment agent
IL259358A (en)	2018-07-31	Bis-pyridazine compounds and their use in treating cancer
IL246637A0 (en)	2016-08-31	Preparations and methods for the treatment of intracerebral hemorrhage
GB201400311D0 (en)	2014-02-26	Treating Susceptibility
SG11201804140PA (en)	2018-06-28	Acidic-gas treating agent and acidic-gas treating method
GB201702652D0 (en)	2017-04-05	Delta-theraphotoxin-Ac1 for use in treating diabetes
GB201510764D0 (en)	2015-08-05	bis-Pyridazine compounds and their use in treating cancer
GB201511503D0 (en)	2015-08-12	Finishing treatment
GB201411111D0 (en)	2014-08-06	bis-Pyridazine compounds and their use in treating cancer
GB201500572D0 (en)	2015-02-25	Sanding apparatus